文献速递浆细胞疾病

多发性骨髓瘤克隆演化与播散的进展特征

Progression signature underlies clonal evolution and dissemination of multiple myeloma.
PubMed 文献 · Blood · 2021-01-01

本研究在MM PrEDiCT异种移植小鼠模型中建立荧光或DNA条形码克隆追踪系统,发现仅少数适应骨髓微环境的克隆能进入循环并定植远处骨髓。原发与远处部位肿瘤细胞RNA测序揭示沿人类MM进展序贯激活的进展特征,与患者总生存显著相关;计算预测28个主调控因子,CRISPR-Cas9体内验证HMGA1和PA2G4在远处骨髓显著耗竭。

要点

  • 仅少数适应骨髓微环境的克隆可进入循环并定植远处骨髓。
  • 进展特征沿人类MM进展序贯激活,与患者总生存显著相关。
  • HMGA1和PA2G4经体内验证参与MM进展与播散。

核心结论

  • MM PrEDiCT模型成功再现人类MM进展关键特征,并鉴定潜在新治疗靶点。

研究设计与样本

  • 在MM PrEDiCT异种移植小鼠模型上建立荧光或DNA条形码克隆追踪系统研究骨髓微环境内克隆行为。

主要发现

  • 仅少数成功适应骨髓微环境的克隆能进入循环并定植远处骨髓。
  • 原发与远处部位MM肿瘤细胞RNA测序揭示沿人类MM进展序贯激活的进展特征,与患者数据集评估时显著关联总生存。
  • 计算预测28个基因为MM进展主调控因子。
  • CRISPR-Cas9体内验证HMGA1和PA2G4在远处骨髓显著耗竭。
  • HMGA1和PA2G4缺失损害MM细胞体外增殖、迁移和黏附能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clonal evolution drives tumor progression, dissemination, and relapse in multiple myeloma (MM), with most patients dying of relapsed disease. This multistage process requires tumor cells to enter the circulation, extravasate, and colonize distant bone marrow (BM) sites. Here, we developed a fluorescent or DNA-barcode clone-tracking system on MM PrEDiCT (progression through evolution and dissemination of clonal tumor cells) xenograft mouse model to study clonal behavior within the BM microenvironment. We showed that only the few clones that successfully adapt to the BM microenvironment can enter the circulation and colonize distant BM sites. RNA sequencing of primary and distant-site MM tumor cells revealed a progression signature sequentially activated along human MM progression and significantly associated with overall survival when evaluated against patient data sets. A total of 28 genes were then computationally predicted to be master regulators (MRs) of MM progression. HMGA1 and PA2G4 were validated in vivo using CRISPR-Cas9 in the PrEDiCT model and were shown to be significantly depleted in distant BM sites, indicating their role in MM progression and dissemination. Loss of HMGA1 and PA2G4 also compromised the proliferation, migration, and adhesion abilities of MM cells in vitro. Overall, our model successfully recapitulates key characteristics of human MM disease progression and identified potential new therapeutic targets for MM.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Shen YJ, Mishima Y, Shi J, et al. Progression signature underlies clonal evolution and dissemination of multiple myeloma. Blood. 2021. PMID: 33150374. doi:10.1182/blood.2020005885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。